Market capitalization | $315.05m |
Enterprise Value | $313.95m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 8.64 |
P/S ratio (TTM) P/S ratio | 8.67 |
P/B ratio (TTM) P/B ratio | 3.61 |
Revenue growth (TTM) Revenue growth | -0.98% |
Revenue (TTM) Revenue | $36.35m |
As a Free StocksGuide user, you can view scores for all 6,897 stocks worldwide.
5 Analysts have issued a Alpha Teknova Inc forecast:
5 Analysts have issued a Alpha Teknova Inc forecast:
Sep '24 |
+/-
%
|
||
Revenue | 36 36 |
1%
1%
|
|
Gross Profit | 5.29 5.29 |
47%
47%
|
|
EBITDA | -21 -21 |
22%
22%
|
EBIT (Operating Income) EBIT | -28 -28 |
14%
14%
|
Net Profit | -32 -32 |
20%
20%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Alpha Teknova, Inc. manufactures cell culture media and supplements. It provides reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. The company's product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. Alpha Teknova was founded by Thomas E. Davis in 1996 and is headquartered in Hollister, CA.
Head office | United States |
CEO | Stephen Gunstream |
Employees | 211 |
Founded | 1996 |
Website | www.teknova.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.